Zhejiang Jingxin Pharmaceutical financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2004 2021 2022 2023 2024
Rev. Revenue
¥301.88M ¥432.59M ¥565.22M ¥510.31M ¥531.47M ¥631.02M ¥709.73M ¥857.58M ¥974.43M ¥1.24B ¥1.42B ¥1.88B ¥2.22B ¥2.94B ¥3.65B ¥3.26B ¥348.22M ¥3.47B ¥3.78B ¥4.00B ¥0.00M
GM % Gross Margin %
32.23% 27.53% 21.86% 28.43% 31.37% 29.93% 26.08% 34.70% 40.97% 46.64% 50.60% 53.79% 58.66% 64.72% 64.84% 60.80% 24.93% 55.39% 53.06% 50.30% 0.00%
OM Operating Margin
12.01% 6.50% 2.18% 2.13% 4.34% 4.76% 7.06% 5.36% 7.30% 9.50% 11.33% 11.90% 11.28% 12.72% 13.33% 15.94% 10.37% 16.67% 16.24% 14.48% 0.00%
EPS Earnings Per Share
¥-0.00 ¥0.02 ¥0.04 ¥0.05 ¥0.21 ¥0.25 ¥0.05 ¥0.37 ¥0.62 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.04 ¥0.06 ¥0.06 ¥0.08 ¥0.17 ¥0.25 ¥0.29 ¥0.29 ¥0.00 ¥0.00 ¥0.00 ¥0.30 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 28.57% 32.00% 340.00% 67.57% 0 0 0 0 0 48.39% 0
Sha. Shares
487.44m 487.44m 487.44m 487.44m 487.44m 487.44m 487.44m 606.39m 606.39m 687.48m 687.48m 767.01m 765.6m 854.76m 824.52m 801.28m 0m 861.03m 816.74m 0m 861.03m
OCF Operating Cash Flow
¥0.00M ¥-1.45M ¥-87.60M ¥29.98M ¥135.38M ¥59.55M ¥69.41M ¥60.28M ¥111.03M ¥210.49M ¥144.69M ¥252.69M ¥385.01M ¥522.94M ¥535.30M ¥513.21M ¥0.00M ¥373.46M ¥855.78M ¥792.84M ¥0.00M
FCF Free Cash Flow
¥0.00M ¥-92.75M ¥-142.45M ¥-13.83M ¥115.20M ¥-96.32M ¥-2.45M ¥-23.23M ¥2.75M ¥115.74M ¥30.67M ¥157.43M ¥276.45M ¥283.96M ¥197.97M ¥179.21M ¥0.00M ¥-33.37M ¥340.21M ¥273.33M ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥-0.19 ¥-0.29 ¥-0.03 ¥0.24 ¥-0.20 ¥-0.00 ¥-0.04 ¥0.00 ¥0.18 ¥0.04 ¥0.21 ¥0.34 ¥0.31 ¥0.23 ¥0.22 ¥0.00 ¥-0.04 ¥0.40 ¥0.32 ¥0.00